These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 34319074)
1. Use of pH-Active Catechol-Bearing Polymeric Nanogels with Glutathione-Responsive Dissociation to Codeliver Bortezomib and Doxorubicin for the Synergistic Therapy of Cancer. Qiu Y; Bai J; Feng Y; Shi X; Zhao X ACS Appl Mater Interfaces; 2021 Aug; 13(31):36926-36937. PubMed ID: 34319074 [TBL] [Abstract][Full Text] [Related]
2. Encapsulation and pH-responsive release of bortezomib by dopamine grafted hyaluronate nanogels. Liu L; Luan S; Zhang C; Wang R; Zhang Y; Zhang M; Sheng Q; Han G; Wang T; Song S Int J Biol Macromol; 2021 Jul; 183():369-378. PubMed ID: 33932413 [TBL] [Abstract][Full Text] [Related]
3. pH and Reduction Dual-Responsive Nanogels as Smart Nanocarriers to Resist Doxorubicin Aggregation. Maruf A; Milewska M; Lalik A; Wandzik I Molecules; 2022 Sep; 27(18):. PubMed ID: 36144713 [TBL] [Abstract][Full Text] [Related]
4. GSH/pH dual-responsive biodegradable camptothecin polymeric prodrugs combined with doxorubicin for synergistic anticancer efficiency. Li J; Hu ZE; Yang XL; Wu WX; Xing X; Gu B; Liu YH; Wang N; Yu XQ Biomater Sci; 2019 Aug; 7(8):3277-3286. PubMed ID: 31180396 [TBL] [Abstract][Full Text] [Related]
5. Catechol polymers for pH-responsive, targeted drug delivery to cancer cells. Su J; Chen F; Cryns VL; Messersmith PB J Am Chem Soc; 2011 Aug; 133(31):11850-3. PubMed ID: 21751810 [TBL] [Abstract][Full Text] [Related]
6. Tumor extracellular acidity activated "off-on" release of bortezomib from a biocompatible dendrimer. Wang M; Wang Y; Hu K; Shao N; Cheng Y Biomater Sci; 2015 Mar; 3(3):480-9. PubMed ID: 26222291 [TBL] [Abstract][Full Text] [Related]
7. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy. Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753 [TBL] [Abstract][Full Text] [Related]
8. Multifunctional Telodendrimer Nanocarriers Restore Synergy of Bortezomib and Doxorubicin in Ovarian Cancer Treatment. Wang L; Shi C; Wright FA; Guo D; Wang X; Wang D; Wojcikiewicz RJH; Luo J Cancer Res; 2017 Jun; 77(12):3293-3305. PubMed ID: 28396359 [TBL] [Abstract][Full Text] [Related]
9. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect. Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017 [TBL] [Abstract][Full Text] [Related]
10. Bortezomib-catechol conjugated prodrug micelles: combining bone targeting and aryl boronate-based pH-responsive drug release for cancer bone-metastasis therapy. Zhu J; Huo Q; Xu M; Yang F; Li Y; Shi H; Niu Y; Liu Y Nanoscale; 2018 Oct; 10(38):18387-18397. PubMed ID: 30256367 [TBL] [Abstract][Full Text] [Related]
11. pH/H Wang Y; Wang J; Gou K; Kang W; Guo X; Zhu K; Li S; Li H ACS Appl Mater Interfaces; 2021 Aug; 13(30):35397-35409. PubMed ID: 34313104 [TBL] [Abstract][Full Text] [Related]
12. Charge-conversional and reduction-sensitive poly(vinyl alcohol) nanogels for enhanced cell uptake and efficient intracellular doxorubicin release. Chen W; Achazi K; Schade B; Haag R J Control Release; 2015 May; 205():15-24. PubMed ID: 25445693 [TBL] [Abstract][Full Text] [Related]
13. Exogenous vitamin C triggered structural changes of redox-activated dual core-crosslinked biodegradable nanogels for boosting the antitumor efficiency. Zhu Y; He Y; Su T; Li C; Cai S; Wu Z; Huang D; Zhang X; Cao J; He B J Mater Chem B; 2020 Jun; 8(23):5109-5116. PubMed ID: 32412025 [TBL] [Abstract][Full Text] [Related]
14. Dual pH-Responsive Shell-Cleavable Polycarbonate Micellar Nanoparticles for in Vivo Anticancer Drug Delivery. Liu S; Ono RJ; Yang C; Gao S; Ming Tan JY; Hedrick JL; Yang YY ACS Appl Mater Interfaces; 2018 Jun; 10(23):19355-19364. PubMed ID: 29757607 [TBL] [Abstract][Full Text] [Related]
15. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy. Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455 [TBL] [Abstract][Full Text] [Related]
16. Acid-degradable lactobionic acid-modified soy protein nanogels crosslinked by ortho ester linkage for efficient antitumor in vivo. Cheng X; Qin J; Wang X; Zha Q; Yao W; Fu S; Tang R Eur J Pharm Biopharm; 2018 Jul; 128():247-258. PubMed ID: 29730261 [TBL] [Abstract][Full Text] [Related]
17. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers. Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983 [TBL] [Abstract][Full Text] [Related]
18. Versatile functionalization of surface-tailorable polymer nanohydrogels for drug delivery systems. Yang WJ; Liang L; Wang X; Cao Y; Xu W; Chang D; Gao Y; Wang L Biomater Sci; 2018 Dec; 7(1):247-261. PubMed ID: 30465554 [TBL] [Abstract][Full Text] [Related]
19. Chitosan based nanogels stepwise response to intracellular delivery kinetics for enhanced delivery of doxorubicin. Zuo Y; Kong M; Mu Y; Feng C; Chen X Int J Biol Macromol; 2017 Nov; 104(Pt A):157-164. PubMed ID: 28600203 [TBL] [Abstract][Full Text] [Related]
20. Smart pH/Redox Dual-Responsive Nanogels for On-Demand Intracellular Anticancer Drug Release. Yang H; Wang Q; Huang S; Xiao A; Li F; Gan L; Yang X ACS Appl Mater Interfaces; 2016 Mar; 8(12):7729-38. PubMed ID: 26960600 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]